These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1671058)

  • 1. Evaluation of a new 2-nitroimidazole nucleoside analogue, RK-28 as a radiosensitizer for clinical use.
    Shibamoto Y; Sasai K; Sakaguchi M; Tamulevicius P; Kitakabu Y; Streffer C; Abe M
    Int J Radiat Biol; 1991 Jan; 59(1):105-15. PubMed ID: 1671058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radiosensitizer: hypoxic cell radiosensitizer].
    Mori T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1399-404. PubMed ID: 2525001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Present status of radiation sensitizers--hypoxic cell radiosensitizer].
    Murayama C; Mori T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2135-41. PubMed ID: 2660744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIH-802, an acetohydroxamic acid derivative of 2-nitroimidazole, as a new potent hypoxic cell radiosensitizer: radiosensitizing activity, acute toxicity, and pharmacokinetics.
    Sasai K; Shibamoto Y; Takahashi M; Zhou L; Hori H; Nagasawa H; Shibata T; Inayama S; Abe M
    Cancer Chemother Pharmacol; 1990; 26(2):112-6. PubMed ID: 2140730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).
    Murayama C; Suzuki A; Suzuki T; Miyata Y; Sakaguchi M; Tanabe Y; Tanaka N; Mori T
    Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):575-81. PubMed ID: 2528527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azomycin riboside: a new radiosensitizer.
    Pedersen JE; Barron G; Chapman JD
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):415-8. PubMed ID: 7107360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of various types of new hypoxic cell sensitizers using the EMT6 single cell-spheroid-solid tumour system.
    Shibamoto Y; Nishimoto S; Mi F; Sasai K; Kagiya T; Abe M
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Sep; 52(3):347-57. PubMed ID: 3497891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitizing, toxicological, and pharmacokinetic properties of hydroxamate analogues of nitroimidazoles as bifunctional radiosensitizers/chemical modifiers.
    Nagasawa H; Bando M; Hori H; Satoh T; Tada T; Onoyama Y; Inayama S
    Int J Radiat Oncol Biol Phys; 1992; 22(3):561-4. PubMed ID: 1735696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new, potent 2-nitroimidazole nucleoside hypoxic cell radiosensitizer, RP170.
    Sasai K; Shibamoto Y; Takahashi M; Abe M; Wang J; Zhou L; Nishimoto S; Kagiya T
    Jpn J Cancer Res; 1989 Nov; 80(11):1113-8. PubMed ID: 2532634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials of radiosensitizers: what should we expect?
    Brown JM
    Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):425-9. PubMed ID: 6231272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiosensitizing effects of new 2-nitroimidazole nucleoside analogues (RK-28, RK-29)].
    Shibamoto Y; Sasai K; Takahashi M; Abe M; Mi FS; Nishimoto S; Kagiya T
    Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):13-8. PubMed ID: 3379329
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of intratumoral RK-28, a new hypoxic radiosensitizer.
    Sasai K; Shibamoto Y; Manabe T; Baba N; Takahashi M; Sakaguchi M; Abe M
    Int J Radiat Oncol Biol Phys; 1992; 24(5):959-63. PubMed ID: 1447037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitization by a new potent nucleoside analog: 1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole(RP-343).
    Murayama C; Suzuki A; Sato C; Tanabe Y; Shoji T; Miyata Y; Nishio A; Suzuki T; Sakaguchi M; Mori T
    Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):433-43. PubMed ID: 8514541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of new hypoxic cell radiosensitizer in Japan].
    Mori T; Murayama C
    Gan No Rinsho; 1988 Oct; 34(13):1869-74. PubMed ID: 2974089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
    Agrawal KC; Rupp WD; Rockwell S
    Radiat Res; 1986 Feb; 105(2):227-39. PubMed ID: 3754053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiosensitization by hypoxic cell radiosensitizer--present status of radiosensitizer].
    Murayama C; Mori T
    Gan No Rinsho; 1990 Oct; 36(13):2249-54. PubMed ID: 2147449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of suppositories for RK-28 (a new radiosensitizer) using rabbits.
    Kim NS; Umejima H; Miyata K; Okubo M; Goto S; Kato T; Mikami Y; Sagitani H; Inoue H
    Biol Pharm Bull; 1994 May; 17(5):672-5. PubMed ID: 7920431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiosensitizing effect of new hypoxic cell radiosensitizer, RK-28 on experimental animal normal tissue and Ehrlich tumor].
    Miyamato Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Aug; 45(8):1142-51. PubMed ID: 3841586
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo radiosensitizing effect of nitroimidazole derivative KIN-804.
    Tada T; Nakajima T; Onoyama Y; Murayama C; Mori T; Nagasawa H; Hori H; Inayama S
    Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):601-5. PubMed ID: 8005823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of X-ray-induced potentially lethal damage (PLD) repair in aerobic plateau-phase Chinese hamster cells by misonidazole.
    Brown DM; Dionet C; Brown JM
    Radiat Res; 1984 Jan; 97(1):162-70. PubMed ID: 6229806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.